Insights

Innovative Therapeutics Cerberus Therapeutics specializes in nanobody-based platforms for immune system modulation, presenting opportunities to collaborate on advanced biologics and bi-specific antibody development for immune-related diseases.

Niche Focus With a focus on autoimmune and infectious diseases, Cerberus offers potential partnerships in these high-demand areas where innovative immune therapies can address unmet medical needs.

Growing Market Presence Operating with a small team yet generating revenue between 1M and 10M, Cerberus presents opportunities to support their growth, scale their research capabilities, and expand their product pipeline.

Advanced Technology Utilizing modern tech stacks such as JSON-LD, Progressive Web Apps, and HTTP/3 indicates a commitment to innovative IT solutions, ideal for proposing integrated digital health solutions or AI-driven research tools.

Funding Potential Although specific funding data is unavailable, Cerberus's innovative approach and strategic focus position it well for future partnership opportunities, grants, or investor collaborations to accelerate development.

Cerberus Therapeutics Tech Stack

Cerberus Therapeutics uses 8 technology products and services including JSON-LD, jQuery Migrate, Polyfill, and more. Explore Cerberus Therapeutics's tech stack below.

JSON-LD

Javascript Frameworks

jQuery Migrate

Javascript Libraries

Polyfill

Javascript Libraries

Lodash

Javascript Libraries

OWL Carousel

Javascript Libraries

PWA

Miscellaneous

Yoast SEO

Search Engines

HTTP/3

Web & Portal Technology

Cerberus Therapeutics Email Formats	Example	Percentage
FLast@cerberustx.com	JDoe@cerberustx.com	50%
FLast@cerberustx.com	JDoe@cerberustx.com	50%

Cerberus Therapeutics Email Formats

Example

Percentage

FLast@cerberustx.com

JDoe@cerberustx.com

50%

FLast@cerberustx.com

JDoe@cerberustx.com

50%

Frequently Asked Questions

Where is Cerberus Therapeutics's headquarters located?

Cerberus Therapeutics's main headquarters is located at 700 Main St, Cambridge, Massachusetts 02139, US. The company has employees across 1 continents, including North America.

What is Cerberus Therapeutics's official website and social media links?

Cerberus Therapeutics's official website is cerberustx.com and has social profiles on LinkedIn.

What is Cerberus Therapeutics's SIC code NAICS code?

Cerberus Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cerberus Therapeutics have currently?

As of October 2025, Cerberus Therapeutics has approximately 7 employees across 1 continents, including North America. Key team members include Co-Founder: N. P.Acting Ceo: T. H.Senior Scientist: L. P.. Explore Cerberus Therapeutics's employee directory with LeadIQ.

What industry does Cerberus Therapeutics belong to?

Cerberus Therapeutics operates in the Biotechnology Research industry.

What technology does Cerberus Therapeutics use?

Cerberus Therapeutics's tech stack includes JSON-LDjQuery MigratePolyfillLodashOWL CarouselPWAYoast SEOHTTP/3.

What is Cerberus Therapeutics's email format?

Cerberus Therapeutics's email format typically follows the pattern of FLast@cerberustx.com. Find more Cerberus Therapeutics email formats with LeadIQ.

When was Cerberus Therapeutics founded?

Cerberus Therapeutics was founded in 2022.

Cerberus Therapeutics

Q: What is Cerberus Therapeutics's official website and social media links?

Cerberus Therapeutics's official website is cerberustx.com. Cerberus Therapeutics has social profiles on LinkedIn.

Q: How many employees does Cerberus Therapeutics have currently?

Cerberus Therapeutics has approximately 7 employees.

Q: What technology does Cerberus Therapeutics use?

Cerberus Therapeutics's tech stack includes jQuery Migrate, jQuery Waypoints, HTTP/3, Yoast SEO, Wix.

Biotechnology ResearchUnited States2-10 Employees

Cerberus Therapeutics utilizes nanobody-based platform to create novel therapeutics for modulating the immune system.

The COVID-19 pandemic highlights the need for safe and accessible therapies to modulate our immune responses. We have developed strategies that allows for precise turning on/off the immune system in response to debilitating diseases.

Our pilot programs focus on autoimmune disorders and infectious diseases, that are based on novel biological discoveries originating from decades of work by our three founders: Dr. Novalia Pishesha, Prof. Hidde Ploegh, and Prof. Harvey Lodish.

Insights

Similar companies to Cerberus Therapeutics

Entrada Therapeutics

LogicBio Therapeutics

AgilVax

Cyteir Therapeutics

GentiBio